Await­ing ex­pand­ed ap­provals, Lil­ly and J&J re­lease late-stage da­ta for Crohn's treat­ments

Eli Lil­ly and John­son & John­son both tout­ed da­ta Mon­day for their IL-23 in­hibitors in Crohn’s dis­ease, with Lil­ly al­so shar­ing long-term da­ta in ul­cer­a­tive …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER